Bio-Path (BPTH) to Release Earnings on Friday

Bio-Path (NASDAQ:BPTH) is set to announce its earnings results before the market opens on Friday, November 15th. Analysts expect the company to announce earnings of ($1.02) per share for the quarter.

Bio-Path (NASDAQ:BPTH) last posted its quarterly earnings data on Thursday, August 15th. The company reported ($1.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.54) by $0.38. During the same period in the previous year, the firm posted ($10.60) EPS. On average, analysts expect Bio-Path to post $-6 EPS for the current fiscal year and $-4 EPS for the next fiscal year.

Bio-Path Stock Down 2.0 %

Shares of Bio-Path stock opened at $0.89 on Friday. Bio-Path has a 52 week low of $0.80 and a 52 week high of $12.43. The stock’s fifty day moving average is $1.00 and its two-hundred day moving average is $1.65.

Analyst Ratings Changes

Separately, StockNews.com started coverage on shares of Bio-Path in a research note on Friday. They issued a “sell” rating on the stock.

About Bio-Path

Bio-Path Holdings, Inc operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction.